Aaron Green Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month ago
Aaron Green has an estimated net worth of at least $10.3 million*, as of Sept. 30, 2026. They own 24,797 shares of ONMD stock. They have sold 132,989 shares of ONMD stock since 2021, for an estimated $166,916.
Aaron Green $ONMD SEC Form 4 Insider Trading
Aaron Green has filed a total of 7 insider trades in $ONMD since 2021. Their most recent trade was a sale of 5,000 shares, made on Sep 22, 2026. Their largest trade was a sale of 64,767 shares, made on Oct 22, 2025. We estimate that they now own 24,797 shares of $ONMD, worth an estimated $10.1 million.
Insider Trading at $ONMD
There have been a total of 95 insider trades reported at $ONMD since 2021, with 8.3 million shares purchased and 141,489 shares sold. The most active insider traders in $ONMD stock have been Jeffrey Yu, Aaron Green, and Robert Lawrence Golden. The most recent trade was a purchase of 129,758 shares reported by Thomas Kosasa (None), made on Oct 07, 2026.
History of Insider Stock Trades by Aaron Green
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ONMD
|
Sale | 5,000 | Sep 22, 2026 | Oct. 9, 2026, 9:30 p.m. |
|
ONMD
|
Sale | 1,667 | Sep 24, 2026 | Oct. 9, 2026, 9:30 p.m. |
|
ONMD
|
Purchase | 36,650 | Jun 23, 2026 | June 24, 2026, 9 a.m. |
|
ONMD
|
Purchase | 18,702 | Jun 15, 2026 | June 16, 2026, 6:04 a.m. |
|
ONMD
|
Purchase | 36,920 | Jun 12, 2026 | June 16, 2026, 6:04 a.m. |
|
ONMD
|
Sale | 64,767 | Oct 22, 2025 | Dec. 23, 2025, 9 p.m. |
|
ONMD
|
Sale | 61,555 | Nov 18, 2025 | Dec. 23, 2025, 9 p.m. |
$ONMD Executives and Stock Owners with Insider Trades
-
Jeffrey Yu, Chief Medical Officer
-
Aaron Green, Chief Executive Officer
-
Robert Lawrence Golden, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.